Liothyronine-structure (Liothyronine Structure)
Liothyronine Sodium Tablet
Product Images NDC 62756-591
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 62756-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-label-25 Mcg (Spl Label 25 Mcg)
This is a prescription drug with the National Drug Code (NDC) of 62756-590-83. It is a medication called Liothyronine Sodium Tablets, USP and comes in a bottle containing 30 tablets made by the company SUN. The label indicates that it is only available with a doctor's prescription and provides a code for referencing the drug information. Unfortunately, no information on its therapeutic uses or indications is given.*
Spl-label-5 Mcg (Spl Label 5 Mcg)
This is a medication for prescription use only called Liothyronine Sodium Tablets USP. The packaging contains 30 tablets from SUN Pharmaceuticals with National Drug Code (NDC) 62756.589-83. Unfortunately, there is no further information available as the text consists only of a few characters and numbers.*
Spl-label-50 Mcg (Spl Label 50 Mcg)
This is a product with the NOC (Canadian drug identification number) 62756.591-63 that is open for full labeling. The product is Liothyronine Sodium Tablets, which is a medication used to treat an underactive thyroid gland. Unfortunately, the dosage, strength, and manufacturer information are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
